Composition
- Active ingredients
- MORPHINE SULFATE 30MG; NALTREXONE HYDROCHLORIDE 1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- MORPHINE SULFATE 80MG; NALTREXONE HYDROCHLORIDE 3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended releaseNDA022321-005 · Discontinued
- MORPHINE SULFATE 50MG; NALTREXONE HYDROCHLORIDE 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended releaseNDA022321-003 · Discontinued
- MORPHINE SULFATE 20MG; NALTREXONE HYDROCHLORIDE 0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended releaseNDA022321-001 · Discontinued
- MORPHINE SULFATE 100MG; NALTREXONE HYDROCHLORIDE 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended releaseNDA022321-006 · Discontinued
- MORPHINE SULFATE 60MG; NALTREXONE HYDROCHLORIDE 2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended releaseNDA022321-004 · Discontinued
- MORPHINE SULFATE 30MG; NALTREXONE HYDROCHLORIDE 1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended releaseThis page
At a glance
- Brand name
- Embeda
- Active substance
- morphine sulfate
- Route
- Oral
- Dosage form
- Capsule, extended release
- Applicant
- Alpharma Pharms
- Status
- Discontinued
- FDA approval
- 13 Aug 2009
- Application
- NDA022321-002